The stock price of Hologic, Inc. (NASDAQ: HOLX) has dropped by -0.36 compared to previous close of 78.38. Despite this, the company has seen a fall of -0.46% in its stock price over the last five trading days. zacks.com reported 2024-07-22 that In the latest trading session, Hologic (HOLX) closed at $78.38, marking a +0.35% move from the previous day.
Is It Worth Investing in Hologic, Inc. (NASDAQ: HOLX) Right Now?
The price-to-earnings ratio for Hologic, Inc. (NASDAQ: HOLX) is 40.18x, which is above its average ratio. Moreover, the 36-month beta value for HOLX is 0.99. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HOLX is 230.35M and currently, short sellers hold a 2.05% of that float. On July 24, 2024, HOLX’s average trading volume was 1.40M shares.
HOLX’s Market Performance
HOLX stock saw an increase of -0.46% in the past week, with a monthly gain of 6.88% and a quarterly increase of 2.47%. The volatility ratio for the week is 1.59%, and the volatility levels for the last 30 days are 1.67% for Hologic, Inc. (HOLX). The simple moving average for the past 20 days is 3.57% for HOLX’s stock, with a 6.61% simple moving average for the past 200 days.
Analysts’ Opinion of HOLX
Many brokerage firms have already submitted their reports for HOLX stocks, with Stephens repeating the rating for HOLX by listing it as a “Overweight.” The predicted price for HOLX in the upcoming period, according to Stephens is $87 based on the research report published on June 27, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see HOLX reach a price target of $95, previously predicting the price at $80. The rating they have provided for HOLX stocks is “Buy” according to the report published on April 03rd, 2024.
Needham gave a rating of “Buy” to HOLX, setting the target price at $95 in the report published on July 14th of the previous year.
HOLX Trading at 4.88% from the 50-Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.28% of loss for the given period.
Volatility was left at 1.67%, however, over the last 30 days, the volatility rate increased by 1.59%, as shares surge +7.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.10% upper at present.
During the last 5 trading sessions, HOLX fell by -0.46%, which changed the moving average for the period of 200-days by +12.91% in comparison to the 20-day moving average, which settled at $75.69. In addition, Hologic, Inc. saw 9.31% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HOLX starting from Stamoulis Christiana, who sale 9,039 shares at the price of $79.50 back on Jul 17 ’24. After this action, Stamoulis Christiana now owns 45,472 shares of Hologic, Inc., valued at $718,600 using the latest closing price.
MACMILLAN STEPHEN P, the Chairman, President and CEO of Hologic, Inc., sale 3,672 shares at $80.13 during a trade that took place back on Jul 17 ’24, which means that MACMILLAN STEPHEN P is holding 1,157,562 shares at $294,223 based on the most recent closing price.
Stock Fundamentals for HOLX
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.5 for the gross margin
The net margin for Hologic, Inc. stands at 0.12. The total capital return value is set at 0.07. Equity return is now at value 9.20, with 5.14 for asset returns.
Based on Hologic, Inc. (HOLX), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 0.43. The debt to equity ratio resting at 0.53. The interest coverage ratio of the stock is 5.04.
Currently, EBITDA for the company is 1.2 billion with net debt to EBITDA at 0.39. When we switch over and look at the enterprise to sales, we see a ratio of 4.7. The receivables turnover for the company is 6.12for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.97.
Conclusion
To wrap up, the performance of Hologic, Inc. (HOLX) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
